Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Primary Prevention of Ischemic Stroke
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Guidelines for the Prevention of Stroke in Women
2014
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]
2005
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
2016
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2008
Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids
2007
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double-Blind, Placebo-Controlled 3-Year Study
2004
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Osteoporosis
2019 Standout
Estrogen receptors and human disease
2006 Standout
Evidence from randomised trials on the long-term effects of hormone replacement therapy
2002
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
2011 Standout
Calcium and Vitamin D in Sarcoidosis: How to Assess and Manage
2010
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Accuracy and completeness of mortality data in the Department of Veterans Affairs
2006
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
2001
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence
2006
Vitamin D Deficiency
2007 Standout
Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
2017
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension
2004
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial
2012
Hormone Replacement Therapy and Prevention of Nonvertebral Fractures
2001
What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
2010
Osteoarthritis
2015 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Is the paradigm shifting?
2003
Sarcoidosis
2013 Standout
Long term hormone therapy for perimenopausal and postmenopausal women
2005
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression
2010
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Does bone resorption inhibition affect the anabolic response to parathyroid hormone?
2004
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
2010
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Age-related macular degeneration
2018 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Postmenopausal Hormone Replacement Therapy
2002
What old means to bone
2010 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
OARSI recommendations for the management of hip and knee osteoarthritis
2010
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
2007 Standout
Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis
2014
The Impact of Monitoring on Adherence and Persistence with Antiresorptive Treatment for Postmenopausal Osteoporosis: A Randomized Controlled Trial
2004
Impact of obesity on long-term prognosis following acute myocardial infarction
2004
The Assessment of Fracture Risk
2010
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two‐year multinational knee osteoarthritis structural arthritis study
2006
The History and Meaning of the Journal Impact Factor
2006 Standout
One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis
2005
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
2006
Epidemiology of Brain Tumors
2008
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club
2005
Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women
2003
Systematic review of the concurrent and predictive validity of MRI biomarkers in OA
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective
2008
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Breast cancer and hormone-replacement therapy in the Million Women Study
2003 Standout
Primary Prevention of Ischemic Stroke
2001
Relationship Between Changes in Bone Mineral Density and Fracture Risk Reduction With Antiresorptive Drugs: Some Issues With Meta-Analyses
2004
Change in Bone Turnover and Hip, Non-Spine, and Vertebral Fracture in Alendronate-Treated Women: The Fracture Intervention Trial
2004
Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate
2003
Relationship between Bone Mineral Density Changes and Fracture Risk Reduction in Patients Treated with Strontium Ranelate
2007
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Hormone Replacement Therapy and Stroke
2004
Change in Lumbar Spine BMD and Vertebral Fracture Risk Reduction in Teriparatide-Treated Postmenopausal Women With Osteoporosis
2006
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
2008
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate
2007
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Noncardiovascular disease outcomes during 6.8 years of hormone therapy. heart and estrogen/progestin replacement study follow-up (HERS II)
2002
Relationship Between Changes in BMD and Nonvertebral Fracture Incidence Associated With Risedronate: Reduction in Risk of Nonvertebral Fracture Is Not Related to Change in BMD
2005
Hormone Replacement Therapy and Cardiovascular Disease
2001
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
2016
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Primary Prevention of Ischemic Stroke
2001
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
2016
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy
2004
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
2005
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Works of Fran Harris being referenced
Cancer mortality study of employees at lead battery plants and lead smelters, 1947-1995
2000
Association Between Thyroid Dysfunction and Total Cholesterol Level in an Older Biracial Population
2002
The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis
2004
Updated Mortality Study of Workers at a Petroleum Refinery in Torrance, California, 1959 to 1997
2001
Effects of hormone replacement therapy on clinical fractures and height loss: the heart and estrogen/progestin replacement study (HERS)
2001
Inclusion of Older Women in Randomized Clinical Trials: Factors Associated with Taking Study Medication in the Fracture Intervention Trial
2000
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
2002
Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)
2002
Postmenopausal Hormone Therapy and Risk of Stroke
2001
Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-Progestin Replacement Study (HERS)
2001
Prediction of Clinical Non-Spine Fractures in Older Black and White Men and Women With Volumetric BMD of the Spine and Areal BMD of the Hip: The Health, Aging, and Body Composition Study
2007